{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T23:14:52Z","timestamp":1772925292354,"version":"3.50.1"},"reference-count":52,"publisher":"Impact Journals, LLC","issue":"46","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2018,6,15]]},"DOI":"10.18632\/oncotarget.25562","type":"journal-article","created":{"date-parts":[[2018,6,15]],"date-time":"2018-06-15T14:38:46Z","timestamp":1529073526000},"page":"28083-28102","source":"Crossref","is-referenced-by-count":5,"title":["Prognostic stratification of adult primary glioblastoma multiforme patients based on their tumor gene amplification profiles"],"prefix":"10.18632","volume":"9","author":[{"given":"Mar\u00eda","family":"Gonz\u00e1lez-Tablas","sequence":"first","affiliation":[{"name":"Centre for Cancer Research (CIC IBMCC-CSIC\/USAL), Department of Medicine, CIBERONC, University of Salamanca, Salamanca, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"In\u00eas","family":"Crespo","sequence":"additional","affiliation":[{"name":"Centre for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal"},{"name":"Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Lu\u00edsa","family":"Vital","sequence":"additional","affiliation":[{"name":"Centre for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal"},{"name":"Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1lvaro","family":"Otero","sequence":"additional","affiliation":[{"name":"Servicio de Neurocirug\u00eda, Hospital Universitario e Instituto Biosanitario de Salamanca (IBSAL), Salamanca, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Bel\u00e9n","family":"Nieto","sequence":"additional","affiliation":[{"name":"Department of Statistics, University of Salamanca, Salamanca, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Sousa","sequence":"additional","affiliation":[{"name":"Servicio de Neurocirug\u00eda, Hospital Universitario e Instituto Biosanitario de Salamanca (IBSAL), Salamanca, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Carmen","family":"Patino-Alonso","sequence":"additional","affiliation":[{"name":"Department of Statistics, University of Salamanca, Salamanca, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Antonio","family":"Corchete","sequence":"additional","affiliation":[{"name":"Departamento de Hematolog\u00eda, Hospital Universitario, IBSAL, IBMCC (USAL-CSIC), Salamanca, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herm\u00ednio","family":"T\u00e3o","sequence":"additional","affiliation":[{"name":"Neurosurgery Service, University Hospital of Coimbra, Coimbra, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olinda","family":"Rebelo","sequence":"additional","affiliation":[{"name":"Neuropathology Laboratory, Neurology Service, University Hospital of Coimbra, Coimbra, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos","family":"Barbosa","sequence":"additional","affiliation":[{"name":"Neurosurgery Service, University Hospital of Coimbra, Coimbra, Portugal"},{"name":"Faculty of Medicine, University of Coimbra, Coimbra, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Ros\u00e1rio","family":"Almeida","sequence":"additional","affiliation":[{"name":"Centre for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Filipa","family":"Guedes","sequence":"additional","affiliation":[{"name":"Centre for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Celeste","family":"Lopes","sequence":"additional","affiliation":[{"name":"Centre for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal"},{"name":"Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pim J.","family":"French","sequence":"additional","affiliation":[{"name":"Department of Neurology, Erasmus MC, Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Orfao","sequence":"additional","affiliation":[{"name":"Centre for Cancer Research (CIC IBMCC-CSIC\/USAL), Department of Medicine, CIBERONC, University of Salamanca, Salamanca, Spain"},{"name":"Instituto Biosanitario de Salamanca (IBSAL), Salamanca, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Dolores","family":"Tabernero","sequence":"additional","affiliation":[{"name":"Centre for Cancer Research (CIC IBMCC-CSIC\/USAL), Department of Medicine, CIBERONC, University of Salamanca, Salamanca, Spain"},{"name":"Instituto Biosanitario de Salamanca (IBSAL), Salamanca, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2018,6,15]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary","volume":"131","author":"Ellison","year":"2016","journal-title":"Acta Neuropathol"},{"key":"2","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/glia.21264","article-title":"The brain tumor microenvironment","volume":"60","author":"Kettenmann","year":"2012","journal-title":"Glia"},{"key":"3","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1073\/pnas.1219747110","article-title":"Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics","volume":"110","author":"Tavare","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2147\/OTT.S120662","article-title":"Strategies of temozolomide in future glioblastoma treatment","volume":"10","author":"Lee","year":"2017","journal-title":"Onco Targets Ther"},{"key":"5","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3322\/caac.20069","article-title":"Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma","volume":"60","author":"Olson","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1476-4598-9-135","article-title":"Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics","volume":"9","author":"Chekenya","year":"2010","journal-title":"Mol Cancer"},{"key":"7","doi-asserted-by":"crossref","first-page":"9065","DOI":"10.1158\/0008-5472.CAN-09-2307","article-title":"Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology","volume":"69","author":"van der Spek","year":"2009","journal-title":"Cancer Res"},{"key":"8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1158\/1078-0432.CCR-09-2268","article-title":"New strategies in the molecular targeting of glioblastoma: how do you hit a moving target?","volume":"17","author":"Mischel","year":"2011","journal-title":"Clin Cancer Res"},{"key":"9","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00401-015-1432-1","article-title":"Glioblastoma: pathology, molecular mechanisms and markers","volume":"129","author":"von Deimling","year":"2015","journal-title":"Acta Neuropathol"},{"key":"10","doi-asserted-by":"crossref","first-page":"e0124178","DOI":"10.1371\/journal.pone.0124178","article-title":"Identification of variants in primary and recurrent glioblastoma using a cancer-specific gene panel and whole exome sequencing","volume":"10","author":"Barnholtz-Sloan","year":"2015","journal-title":"PLoS One"},{"key":"11","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1073\/pnas.1114033109","article-title":"Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response","volume":"109","author":"Brennan","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"12","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature07385","article-title":"Comprehensive genomic characterization defines human glioblastoma genes and core pathways","volume":"455","author":"The Cancer Genome Atlas (TCGA) Research Network","year":"2008","journal-title":"Nature"},{"key":"13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ccr.2006.02.019","article-title":"Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis","volume":"9","author":"Feuerstein","year":"2006","journal-title":"Cancer Cell"},{"key":"14","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","article-title":"Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1","volume":"17","author":"O'Kelly","year":"2010","journal-title":"Cancer Cell"},{"key":"15","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1158\/1541-7786.MCR-08-0270","article-title":"High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray","volume":"7","author":"Dugas","year":"2009","journal-title":"Mol Cancer Res"},{"key":"16","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","article-title":"The somatic genomic landscape of glioblastoma","volume":"155","author":"Wu","year":"2013","journal-title":"Cell"},{"key":"17","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1215\/15228517-2009-025","article-title":"IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas","volume":"11","author":"Collins","year":"2009","journal-title":"Neuro Oncol"},{"key":"18","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1593\/neo.10688","article-title":"Epidermal growth factor receptor in glioma: signal transduction, neuropathology, imaging, and radioresistance","volume":"12","author":"Habib","year":"2010","journal-title":"Neoplasia"},{"key":"19","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1158\/0008-5472.CAN-08-1547","article-title":"Epidermal growth factor receptor and PTEN modulate tissue factor expression in glioblastoma through JunD\/activator protein-1 transcriptional activity","volume":"69","author":"Brat","year":"2009","journal-title":"Cancer Res"},{"key":"20","doi-asserted-by":"crossref","first-page":"e46088","DOI":"10.1371\/journal.pone.0046088","article-title":"Amplified and homozygously deleted genes in glioblastoma: impact on gene expression levels","volume":"7","author":"Tabernero","year":"2012","journal-title":"PLoS One"},{"key":"21","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jmoldx.2011.06.003","article-title":"Detailed characterization of alterations of chromosomes 7, 9, and 10 in glioblastomas as assessed by single-nucleotide polymorphism arrays","volume":"13","author":"Tabernero","year":"2011","journal-title":"J Mol Diagn"},{"key":"22","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10048-009-0217-x","article-title":"Intratumoral patterns of clonal evolution in gliomas","volume":"11","author":"Orfao","year":"2010","journal-title":"Neurogenetics"},{"key":"23","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/nature08822","article-title":"The landscape of somatic copy-number alteration across human cancers","volume":"463","author":"Ligon","year":"2010","journal-title":"Nature"},{"key":"24","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1215\/15228517-2008-113","article-title":"Comparative analyses of gene copy number and mRNA expression in glioblastoma multiforme tumors and xenografts","volume":"11","author":"Berger","year":"2009","journal-title":"Neuro Oncol"},{"key":"25","first-page":"5141","article-title":"Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4\/SAS and MDM2 as independent amplification targets","volume":"56","author":"Collins","year":"1996","journal-title":"Cancer Res"},{"key":"26","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/ijc.11023","article-title":"Refined mapping of 1q32 amplicons in malignant gliomas confirms MDM4 as the main amplification target","volume":"104","author":"Reifenberger","year":"2003","journal-title":"Int J Cancer"},{"key":"27","first-page":"1602","article-title":"Gene expression-based classification of malignant gliomas correlates better with survival than histological classification","volume":"63","author":"Pomeroy","year":"2003","journal-title":"Cancer Res"},{"key":"28","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ccr.2009.12.049","article-title":"A hierarchy of self-renewing tumor-initiating cell types in glioblastoma","volume":"17","author":"Guerrero","year":"2010","journal-title":"Cancer Cell"},{"key":"29","doi-asserted-by":"crossref","first-page":"20007","DOI":"10.1073\/pnas.0710052104","article-title":"Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma","volume":"104","author":"Thomas","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"30","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1215\/15228517-2008-064","article-title":"Prevalence of copy-number neutral LOH in glioblastomas revealed by genomewide analysis of laser-microdissected tissues","volume":"10","author":"Hayashi","year":"2008","journal-title":"Neuro Oncol"},{"key":"31","doi-asserted-by":"crossref","first-page":"10300","DOI":"10.1158\/0008-5472.CAN-08-3272","article-title":"Mutational inactivation of PTPRD in glioblastoma multiforme and malignant melanoma","volume":"68","author":"Waldman","year":"2008","journal-title":"Cancer Res"},{"key":"32","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/gcc.20760","article-title":"Integrated genomic profiling identifies candidate genes implicated in glioma-genesis and a novel LEO1-SLC12A1 fusion gene","volume":"49","author":"French","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"key":"33","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nrg3871","article-title":"A copy number variation map of the human genome","volume":"16","author":"Scherer","year":"2015","journal-title":"Nat Rev Genet"},{"key":"34","doi-asserted-by":"crossref","first-page":"e94871","DOI":"10.1371\/journal.pone.0094871","article-title":"Prevalence and clinicopathologic characteristics of the molecular subtypes inmalignant glioma: a multi-institutional analysis of 941 cases","volume":"9","author":"You","year":"2014","journal-title":"PLoS One"},{"key":"35","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1093\/neuonc\/nos263","article-title":"Molecular classification of gliomas based on whole genome gene expression: a systematic report of 225 samples from the Chinese Glioma Cooperative Group","volume":"14","author":"Jiang","year":"2012","journal-title":"Neuro Oncol"},{"key":"36","doi-asserted-by":"crossref","first-page":"e0164649","DOI":"10.1371\/journal.pone.0164649","article-title":"Identification of an Efficient Gene Expression Panel for Glioblastoma Classification","volume":"11","author":"Coppola","year":"2016","journal-title":"PLoS One"},{"key":"37","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1097\/PAS.0b013e3182518e12","article-title":"Paradoxical relationship between the degree of EGFR amplification and outcome in glioblastomas","volume":"36","author":"Horbinski","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"38","doi-asserted-by":"publisher","first-page":"618","DOI":"10.18632\/oncoscience.178","article-title":"Whole genome sequence analysis links chromothripsis to EGFR, MDM2, MDM4, and CDK4 amplification in glioblastoma","volume":"2","author":"Bahassiel","year":"2015","journal-title":"Oncoscience"},{"key":"39","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s11060-015-1974-z","article-title":"Association between RAD 51 rs1801320 and susceptibility to glioblastoma","volume":"126","author":"Naccarato","year":"2016","journal-title":"J Neurooncol"},{"key":"40","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1750-3639.2009.00320.x","article-title":"Robust detection of EGFR copy number changes and EGFR variant III: technical aspects and relevance for glioma diagnostics","volume":"19","author":"Wesseling","year":"2009","journal-title":"Brain Pathol"},{"key":"41","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1136\/jcp.2009.074898","article-title":"Age-dependent prognostic effects of EGFR\/p53 alterations in glioblastoma: study on a prospective cohort of 140 uniformly treated adult patients","volume":"63","author":"Santosh","year":"2010","journal-title":"J Clin Pathol"},{"key":"42","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1073\/pnas.1414573112","article-title":"Genomically amplified Akt3 activates DNA repair pathway and promotes glioma progression","volume":"112","author":"Fuller","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"43","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/neuonc\/4.2.86","article-title":"A chromosomal region 7p11.2 transcript map: its development and application to the study of EGFR amplicons in glioblastoma","volume":"4","author":"James","year":"2002","journal-title":"Neuro Oncol"},{"key":"44","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1091\/mbc.e14-01-0004","article-title":"Lanthionine synthetase C-like protein 2 (LanCL2) is a novel regulator of Akt","volume":"25","author":"Chen","year":"2014","journal-title":"Mol Biol Cell"},{"key":"45","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.bbamem.2006.07.018","article-title":"Myristoylation of human LanC-like protein 2 (LANCL2) is essential for the interaction with the plasma membrane and the increase in cellular sensitivity to adriamycin","volume":"1758","author":"Prohaska","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"46","doi-asserted-by":"crossref","first-page":"9043","DOI":"10.1038\/s41598-017-08940-9","article-title":"EGFR and PDGFRA co-expression and heterodimerization in glioblastoma tumor sphere lines","volume":"7","author":"Brennan","year":"2017","journal-title":"Sci Rep"},{"key":"47","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1080\/15384101.2015.1010866","article-title":"Evidence for a CDK4-dependent checkpoint in a conditional model of cellular senescence","volume":"14","author":"Peters","year":"2015","journal-title":"Cell Cycle"},{"key":"48","doi-asserted-by":"publisher","first-page":"228","DOI":"10.18632\/oncotarget.443","article-title":"Regulation of p53: a collaboration between Mdm2 and Mdmx","volume":"3","author":"Zheng","year":"2012","journal-title":"Oncotarget"},{"key":"49","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1091\/mbc.e05-11-1083","article-title":"Phosphoinositide 3-Kinase C2beta regulates cytoskeletal organization and cell migration via Rac-dependent mechanisms","volume":"17","author":"Arcaro","year":"2006","journal-title":"Mol Biol Cell"},{"key":"50","first-page":"39","article-title":"Glioblastoma Multiforme Oncogenomics and Signaling Pathways","volume":"3","author":"Adamson","year":"2009","journal-title":"Clin Med Oncol"},{"key":"51","doi-asserted-by":"crossref","first-page":"e45475","DOI":"10.1371\/journal.pone.0045475","article-title":"A simplified approach for the molecular classification of glioblastomas","volume":"7","author":"Salmon","year":"2012","journal-title":"PLoS One"},{"key":"52","unstructured":"Tabernero. A method for the global detection of chromosomal gains and losses, and an array for assessing genetic abnormalities. Spanish patent n\u00b0 2012318929 and European Trade Mark Register \u201cFullChromArray\u201d n\u00b0 11057627 and United States TM number 85826459. 2012 Nov; p. 27."}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.25562","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T14:17:11Z","timestamp":1720361831000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.25562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,15]]},"references-count":52,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2018,6,15]]}},"alternative-id":["25562","29963263"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.25562","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,15]]}}}